These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15170023)

  • 1. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.
    Bochenek G; Nizankowska E; Gielicz A; Swierczyńska M; Szczeklik A
    Thorax; 2004 Jun; 59(6):459-64. PubMed ID: 15170023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge.
    Bochenek G; Nagraba K; Nizankowska E; Szczeklik A
    J Allergy Clin Immunol; 2003 Apr; 111(4):743-9. PubMed ID: 12704352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.
    Nittner-Marszalska M; Cichocka-Jarosz E; Sanak M; Wujczyk M; Dor-Wojnarowska A; Lis G; Liebhart J
    Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):317-25. PubMed ID: 25763689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
    Misso NL; Aggarwal S; Thompson PJ; Vally H
    Int Arch Allergy Immunol; 2009; 149(2):127-32. PubMed ID: 19127069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
    Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
    Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and urinary leukotriene E4 and 9α,11β-prostaglandin F2 release after exercise challenge.
    Baek HS; Choi JH; Oh JW; Lee HB
    Ann Allergy Asthma Immunol; 2013 Aug; 111(2):112-7. PubMed ID: 23886229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.
    O'Sullivan S; Roquet A; Dahlén B; Dahlén S; Kumlin M
    Clin Exp Allergy; 1998 Nov; 28(11):1332-9. PubMed ID: 9824404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
    O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
    J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in children.
    Cichocka-Jarosz E; Sanak M; Szczeklik A; Brzyski P; Gielicz A; Pietrzyk JJ
    J Investig Allergol Clin Immunol; 2011; 21(4):260-9. PubMed ID: 21721371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of mast cell activation and leukotriene release after mannitol inhalation.
    Brannan JD; Gulliksson M; Anderson SD; Chew N; Kumlin M
    Eur Respir J; 2003 Sep; 22(3):491-6. PubMed ID: 14516140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers.
    Higashi N; Mita H; Ono E; Fukutomi Y; Yamaguchi H; Kajiwara K; Tanimoto H; Sekiya K; Akiyama K; Taniguchi M
    J Allergy Clin Immunol; 2010 May; 125(5):1084-1091.e6. PubMed ID: 20304469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children.
    Cichocka-Jarosz E; Sanak M; Szczeklik A; Brzyski P; Pietrzyk JJ
    Ann Agric Environ Med; 2014; 21(2):294-301. PubMed ID: 24959779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
    Mita H; Endoh S; Kudoh M; Kawagishi Y; Kobayashi M; Taniguchi M; Akiyama K
    Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed asthmatic response to bronchial challenge with allergen-mediators, eicosanoids, eosinophil and neutrophil constituents in the blood and urine.
    Pelikan Z
    Respiration; 2011; 82(3):225-36. PubMed ID: 21454958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GC/MS analysis of urinary excretion of 9alpha,11beta-PGF2 in acute and exercise-induced asthma in children.
    Nagakura T; Obata T; Shichijo K; Matsuda S; Sigimoto H; Yamashita K; Masaki T; Maekawa K
    Clin Exp Allergy; 1998 Feb; 28(2):181-6. PubMed ID: 9515591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.
    Shin TR; Kim JH; Kim CH; Hyun IG; Choi JH
    J Thorac Dis; 2015 Jul; 7(7):1198-204. PubMed ID: 26380736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for mast cell activation during exercise-induced bronchoconstriction.
    O'Sullivan S; Roquet A; Dahlén B; Larsen F; Eklund A; Kumlin M; O'Byrne PM; Dahlén SE
    Eur Respir J; 1998 Aug; 12(2):345-50. PubMed ID: 9727783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary 9alpha,11beta-prostaglandin F(2) in children with atopic eczema/dermatitis syndrome: an indicator of mast cell activation?
    Øymar K; Aksnes L
    Acta Derm Venereol; 2004; 84(5):359-62. PubMed ID: 15370701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.